This study examined how parvalbumin (PV) interneuron state dynamics regulate gamma oscillations in awake mice, and whether these dynamics are disrupted in J20 Alzheimer's disease (AD) mice, using simultaneous calcium imaging and electrocorticography (ECoG).
PV interneurons showed sequential recruitment and transient inactivation (dynamic functional networks) during gamma oscillations; in J20 AD mice, these state transitions were dysregulated, causing impaired PV–gamma coupling and network hyperexcitability. Restoring interneuron excitability via Nav1.1 expression rescued PV cell dynamics, gamma oscillations, and network stability.
Findings are based on a single transgenic mouse model of AD (J20), which may not capture the full complexity of human Alzheimer's disease. The study is preclinical, so direct translation to human clinical interventions remains speculative.
While not yet clinical, these findings suggest that targeting PV interneuron excitability (e.g., via Nav1.1 upregulation) could be a mechanistic strategy to restore gamma oscillations and reduce network hyperexcitability in Alzheimer's disease. Clinicians should be aware that gamma oscillation deficits in AD may reflect specific circuit-level PV interneuron dysfunction, not simply a uniform loss of inhibition.